Plasma vascular endothelial growth factor levels are similar in subjects with and without osteoporosis;Osteoporozu olan ve olmayan olgularda serum vasküler endotelyal büyüme faktörü düzeyleri aynıdır

Eklem Hastaliklari ve Cerrahisi

Volumn 21, Issue 2, 2010, Pages 91-97

  Çebi, Hakan ^a   Akşahin, Ertuǧrul ^a   Yüksel, Halil Yalçin ^a   Çelebi, Levent ^a   Aktekin, Cem Nuri ^a   Hapa, Onur ^a   Muratli, Hasan Hilmi ^b   Biçimoǧlu, Ali ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Sakarya Training and Research Hospital   (Turkey)

Author keywords

Bone mineral density; Osteoporosis; Vascular endothelial growth factors

Indexed keywords

EID: 77956272781     PISSN: 13058282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Frost HM. The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Miner 1987;2:73-85.
2. Parfitt AM. The mechanism of coupling: a role for the vasculature. Bone 2000;26:319-23.
3. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002;99:9656-61.
4. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999;5:623-8.
5. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nature Medicine 2003;9:669-76
6. Carlevaro MF, Cermelli S, Cancedda R, Descalzi Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 2000;113:59-69.
7. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol. 2001;280:C1358-66.
8. Zelzer E, McLean W, Ng YS, Fukai N, Reginato AM, Lovejoy S, D'Amore PA, Olsen BR. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002; 129: 1893-904.
9. Keramaris NC, Calori GM, Nikolaou VS, Schemitsch EH, Giannoudis PV. Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury 2008;39 Suppl 2:S45-57.
10. Street J, Winter D, Wang JH, Wakai A, McGuinness A, Redmond HP. Is human fracture hematoma inherently angiogenic? Clin Orthop Relat Res 2000;378:224-37.
11. Costa N, Paramanathan S, Mac Donald D, Wierzbicki AS, Hampson G. Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis. Cytokine 2009;46:376-81.
12. Pufe T, Scholz-Ahrens KE, Franke AT, Petersen W, Mentlein R, Varoga D, Tillmann B, Schrezenmeir J, Glüer CC. The role of vascular endothelial growth factor in glucocorticoid-induce bone loss: evaluation in a minipig model. Bone 2003;33:869-76.
13. Pufe T, Claassen H, Scholz-Ahrens KE, Varoga D, Drescher W, Franke AT, et al. Influence of estradiol on vascular endothelial growth factor expression in bone: a study in Gottingen miniature pigs and human osteoblasts. Calcif Tissue Int 2007;80:184-91.
14. Mao-wei Y, Yue Z, Guan-jun T, Gang L. Effect of fluvastatin on vascular endothelial growth factor in rats with osteoporosis in process of fracture healing. Chin J Traumatol 2007;10:306-10.
15. Hiltunen MO, Ruuskanen M, Huuskonen J, Mähönen AJ, Ahonen M, Rutanen J, et al. Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. FASEB J 2003; 17: 1147-9.
16. Miyaura C, Kusano K, Masuzawa T, Chaki O, Onoe Y, Aoyagi M, et al. Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6. J Bone Miner Res 1995;10:1365-73.
17. Wang DS, Miura M, Demura H, Sato K. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology 1997; 138: 2953-62.
18. Kodama I, Niida S, Sanada M, Yoshiko Y, Tsuda M, Maeda N, et al. Estrogen regulates the production of VEGF for osteoclast formation and activity in op/op mice. J Bone Miner Res 2004;19:200-6.
19. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 1999;190:293-8.
20. Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley ER, et al. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 1993;91:257-63.
21. Raisz LG, Fall PM. Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology 1990;126:1654-9.
22. Shinar DM, Rodan GA. Biphasic effects of transforming growth factor-beta on the production of osteoclastlike cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells. Endocrinology 1990;126:3153-8.
23. Harada S, Nagy JA, Sullivan KA, Thomas KA, Endo N, Rodan GA, et al. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994;93:2490-6.